CVS Agrees to $36M Settlement Over Insulin Billing Allegations

WHO:

CT News Junkie - Connecticut and a group of other states reached a settlement with CVS Pharmacy.

WTNH - Connecticut Attorney General William Tong announced the settlement.

WHAT:

CT News Junkie - CVS Pharmacy agreed to a $35 million settlement.

WTNH - CVS Pharmacy will pay $36.5 million to resolve allegations of fraudulent overbilling of Medicaid for insulin prescriptions.

WHERE:

WTNH - The settlement involves CVS Pharmacy, which operates in Connecticut and other states.

WHEN:

WTNH - The allegations pertain to actions taken from 2010 through 2020.

WHY:

WTNH - The settlement resolves allegations that CVS violated the False Claims Act by knowingly billing and dispensing false claims to the Medicaid program related to insulin pens.

HOW:

WTNH - CVS allegedly submitted or caused to be submitted false claims to the Medicaid program regarding insulin prescriptions.

(UPDATED July 6, 2026 21:27 UTC)

Connecticut and several other states have reached a settlement with CVS Pharmacy, as announced by Connecticut Attorney General William Tong. CVS has agreed to pay a total of $36.5 million to resolve allegations of fraudulent overbilling of Medicaid for insulin prescriptions, which stem from actions taken between 2010 and 2020. The settlement addresses claims that CVS violated the False Claims Act by knowingly submitting false claims to the Medicaid program related to insulin pens.